Pharmanet into phase 1 clinical trials

WA-LISTED pharmaceutical group Pharmanet has announced that its subsidiary, Molecular Pharmacology Limited, has received approval for the commencement of human trials into the effectiveness of its Thermalife Cream and its analgesic and anti-inflammatory compound Tripeptofen. The company believes the trials, which are for the purpose of evaluating the effect of the two products on pain and function, are a significant step towards achieving commercial sales of the cream.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer